CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

CCN family protein 2/connective tissue growth factor (CCN2/CTGF) is a multi-potent factor for mesenchymal cells such as chondrocytes, osteoblasts, osteoclasts, and endothelial cells. CCN2 is also known as a modulator of other cytokines and receptors via direct molecular interactions with them. We screened additional factors binding to CCN2 and found receptor activator of NF-kappa B (RANK) as one of them. RANK is also known as TNF-related activation-induced cytokine (TRANCE) receptor, and its signaling plays a critical role in osteoclastogenesis. Notable affinity between CCN2 and RANK was confirmed by using surface plasmon resonance (SPR) analysis. In fact, CCN2 enhanced the RANK-mediated signaling, such as occurs in NF-kappa B, p38 and JNK pathways, in pre-osteoclastic RAW264.7 cells; whereas CCN2 had no influence on RANK-RANK ligand (RANKL) binding. Moreover, CCN2 also significantly bound to osteoprotegerin (OPG), which is a decoy receptor of RANKL. Of note, OPG markedly inhibited the binding between CCN2 and RANK; and CCN2 canceled the inhibitory effect of OPG on osteoclast differentiation. These findings suggest CCN2 as a candidate of the fourth factor in the RANK/RANKL/OPG system for osteoclastogenesis, which regulates OPG and RANK via direct interaction.

Original languageEnglish
Pages (from-to)242-248
Number of pages7
JournalBone
Volume73
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Receptor Activator of Nuclear Factor-kappa B
RANK Ligand
Osteoprotegerin
Osteoclasts
Cytokine Receptors
Osteogenesis
CCN Intercellular Signaling Proteins
Connective Tissue Growth Factor
Surface Plasmon Resonance
MAP Kinase Signaling System
NF-kappa B
Chondrocytes
Osteoblasts

Keywords

  • CCN2 family protein 2 (CCN2)
  • Osteoclast
  • Osteoprotegerin (OPG)
  • RANK ligand (RANKL)
  • Receptor activator of nuclear factor-κB ligand (RANK)

ASJC Scopus subject areas

  • Physiology
  • Endocrinology, Diabetes and Metabolism
  • Histology
  • Medicine(all)

Cite this

CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG. / Aoyama, Eriko; Kubota, Satoshi; Khattab, Hany Mohamed; Nishida, Takashi; Takigawa, Masaharu.

In: Bone, Vol. 73, 01.04.2015, p. 242-248.

Research output: Contribution to journalArticle

@article{0be6298aa96c418da76371b9078d4092,
title = "CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG",
abstract = "CCN family protein 2/connective tissue growth factor (CCN2/CTGF) is a multi-potent factor for mesenchymal cells such as chondrocytes, osteoblasts, osteoclasts, and endothelial cells. CCN2 is also known as a modulator of other cytokines and receptors via direct molecular interactions with them. We screened additional factors binding to CCN2 and found receptor activator of NF-kappa B (RANK) as one of them. RANK is also known as TNF-related activation-induced cytokine (TRANCE) receptor, and its signaling plays a critical role in osteoclastogenesis. Notable affinity between CCN2 and RANK was confirmed by using surface plasmon resonance (SPR) analysis. In fact, CCN2 enhanced the RANK-mediated signaling, such as occurs in NF-kappa B, p38 and JNK pathways, in pre-osteoclastic RAW264.7 cells; whereas CCN2 had no influence on RANK-RANK ligand (RANKL) binding. Moreover, CCN2 also significantly bound to osteoprotegerin (OPG), which is a decoy receptor of RANKL. Of note, OPG markedly inhibited the binding between CCN2 and RANK; and CCN2 canceled the inhibitory effect of OPG on osteoclast differentiation. These findings suggest CCN2 as a candidate of the fourth factor in the RANK/RANKL/OPG system for osteoclastogenesis, which regulates OPG and RANK via direct interaction.",
keywords = "CCN2 family protein 2 (CCN2), Osteoclast, Osteoprotegerin (OPG), RANK ligand (RANKL), Receptor activator of nuclear factor-κB ligand (RANK)",
author = "Eriko Aoyama and Satoshi Kubota and Khattab, {Hany Mohamed} and Takashi Nishida and Masaharu Takigawa",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.bone.2014.12.058",
language = "English",
volume = "73",
pages = "242--248",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG

AU - Aoyama, Eriko

AU - Kubota, Satoshi

AU - Khattab, Hany Mohamed

AU - Nishida, Takashi

AU - Takigawa, Masaharu

PY - 2015/4/1

Y1 - 2015/4/1

N2 - CCN family protein 2/connective tissue growth factor (CCN2/CTGF) is a multi-potent factor for mesenchymal cells such as chondrocytes, osteoblasts, osteoclasts, and endothelial cells. CCN2 is also known as a modulator of other cytokines and receptors via direct molecular interactions with them. We screened additional factors binding to CCN2 and found receptor activator of NF-kappa B (RANK) as one of them. RANK is also known as TNF-related activation-induced cytokine (TRANCE) receptor, and its signaling plays a critical role in osteoclastogenesis. Notable affinity between CCN2 and RANK was confirmed by using surface plasmon resonance (SPR) analysis. In fact, CCN2 enhanced the RANK-mediated signaling, such as occurs in NF-kappa B, p38 and JNK pathways, in pre-osteoclastic RAW264.7 cells; whereas CCN2 had no influence on RANK-RANK ligand (RANKL) binding. Moreover, CCN2 also significantly bound to osteoprotegerin (OPG), which is a decoy receptor of RANKL. Of note, OPG markedly inhibited the binding between CCN2 and RANK; and CCN2 canceled the inhibitory effect of OPG on osteoclast differentiation. These findings suggest CCN2 as a candidate of the fourth factor in the RANK/RANKL/OPG system for osteoclastogenesis, which regulates OPG and RANK via direct interaction.

AB - CCN family protein 2/connective tissue growth factor (CCN2/CTGF) is a multi-potent factor for mesenchymal cells such as chondrocytes, osteoblasts, osteoclasts, and endothelial cells. CCN2 is also known as a modulator of other cytokines and receptors via direct molecular interactions with them. We screened additional factors binding to CCN2 and found receptor activator of NF-kappa B (RANK) as one of them. RANK is also known as TNF-related activation-induced cytokine (TRANCE) receptor, and its signaling plays a critical role in osteoclastogenesis. Notable affinity between CCN2 and RANK was confirmed by using surface plasmon resonance (SPR) analysis. In fact, CCN2 enhanced the RANK-mediated signaling, such as occurs in NF-kappa B, p38 and JNK pathways, in pre-osteoclastic RAW264.7 cells; whereas CCN2 had no influence on RANK-RANK ligand (RANKL) binding. Moreover, CCN2 also significantly bound to osteoprotegerin (OPG), which is a decoy receptor of RANKL. Of note, OPG markedly inhibited the binding between CCN2 and RANK; and CCN2 canceled the inhibitory effect of OPG on osteoclast differentiation. These findings suggest CCN2 as a candidate of the fourth factor in the RANK/RANKL/OPG system for osteoclastogenesis, which regulates OPG and RANK via direct interaction.

KW - CCN2 family protein 2 (CCN2)

KW - Osteoclast

KW - Osteoprotegerin (OPG)

KW - RANK ligand (RANKL)

KW - Receptor activator of nuclear factor-κB ligand (RANK)

UR - http://www.scopus.com/inward/record.url?scp=84922523169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922523169&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2014.12.058

DO - 10.1016/j.bone.2014.12.058

M3 - Article

VL - 73

SP - 242

EP - 248

JO - Bone

JF - Bone

SN - 8756-3282

ER -